发明授权
- 专利标题： β-ketoamide compounds with MCH antagonistic activity
- 专利标题（中）： 具有MCH拮抗活性的β-酮酰胺化合物
-
申请号： US11071797申请日： 2005-03-03
-
公开(公告)号： US07605176B2公开(公告)日： 2009-10-20
- 发明人: Gerald Juergen Roth , Philipp Lustenberger , Dirk Stenkamp , Stephan Georg Mueller , Thorsten Lehmann-Lintz , Marcus Schindler , Leo Thomas , Ralf R. H. Lotz , Marco Santagostino
- 申请人： Gerald Juergen Roth , Philipp Lustenberger , Dirk Stenkamp , Stephan Georg Mueller , Thorsten Lehmann-Lintz , Marcus Schindler , Leo Thomas , Ralf R. H. Lotz , Marco Santagostino
- 申请人地址： DE Ingelheim
- 专利权人： Boehringer Ingelheim International GmbH
- 当前专利权人： Boehringer Ingelheim International GmbH
- 当前专利权人地址： DE Ingelheim
- 代理商 Michael P. Morris; Mary-Ellen M. Devlin; Timothy X. Wltkowski
- 优先权： DE102004010893 20040306
- 主分类号： A01N43/36
- IPC分类号： A01N43/36 ; C07D207/00 ; C07D295/00
摘要：
Compounds of formula I wherein the groups and residues A, B, b, X, Y, Z, R1, R2, R3, R5a and R5b have the meanings given in claim 1. The invention further relates to pharmaceutical compositions containing at least one amide according to the invention. As a result of their MCH-receptor antagonistic activity the pharmaceutical compositions according to the invention are suitable for the treatment of metabolic disorders and/or eating disorders, particularly obesity, bulimia, anorexia, hyperphagia, and diabetes.
公开/授权文献
- US20050245500A1 Beta-ketoamide compounds with MCH antagonistic activity 公开/授权日：2005-11-03
信息查询
IPC分类:
